HEADER ANTITUMOR PROTEIN 26-SEP-23 8WJY TITLE PKMYT1_COCRYSTAL_CPD 4 COMPND MOL_ID: 1; COMPND 2 MOLECULE: MEMBRANE-ASSOCIATED TYROSINE- AND THREONINE-SPECIFIC CDC2- COMPND 3 INHIBITORY KINASE; COMPND 4 CHAIN: A; COMPND 5 SYNONYM: MYT1 KINASE; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PKMYT1, MYT1; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA PHAGE ECSZW-2; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 2419741 KEYWDS INHIBITOR, CO-CRYSTAL, ANTITUMOR PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.WANG,C.WANG,T.LIU,H.QI,S.CHEN,X.CAI,M.ZHANG,A.ALIPER,F.REN,X.DING, AUTHOR 2 A.ZHAVORONKOV REVDAT 2 29-MAY-24 8WJY 1 JRNL REVDAT 1 22-NOV-23 8WJY 0 JRNL AUTH Y.WANG,C.WANG,T.LIU,H.QI,S.CHEN,X.CAI,M.ZHANG,A.ALIPER, JRNL AUTH 2 F.REN,X.DING,A.ZHAVORONKOV JRNL TITL DISCOVERY OF TETRAHYDROPYRAZOLOPYRAZINE DERIVATIVES AS JRNL TITL 2 POTENT AND SELECTIVE MYT1 INHIBITORS FOR THE TREATMENT OF JRNL TITL 3 CANCER. JRNL REF J.MED.CHEM. V. 67 420 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38146659 JRNL DOI 10.1021/ACS.JMEDCHEM.3C01476 REMARK 2 REMARK 2 RESOLUTION. 1.88 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.88 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 56.96 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 23376 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.174 REMARK 3 R VALUE (WORKING SET) : 0.172 REMARK 3 FREE R VALUE : 0.217 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1213 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.88 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.93 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1729 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.94 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE SET COUNT : 85 REMARK 3 BIN FREE R VALUE : 0.3780 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2272 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 271 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.24 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.69000 REMARK 3 B22 (A**2) : 0.35000 REMARK 3 B33 (A**2) : -2.04000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.148 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.139 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.101 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 3.515 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.961 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.941 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2411 ; 0.010 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2277 ; 0.001 ; 0.015 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3266 ; 1.586 ; 1.667 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5242 ; 1.356 ; 1.588 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 296 ; 8.754 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 133 ;26.435 ;20.977 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 396 ;13.065 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 22 ;19.400 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 277 ; 0.082 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2748 ; 0.012 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 566 ; 0.001 ; 0.021 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1184 ; 2.568 ; 2.705 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1183 ; 2.567 ; 2.701 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1477 ; 3.903 ; 4.023 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1478 ; 3.902 ; 4.027 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1227 ; 3.142 ; 3.067 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1228 ; 3.141 ; 3.068 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1789 ; 4.835 ; 4.450 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2826 ; 7.535 ;32.358 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2767 ; 7.412 ;31.904 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8WJY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBC ON 29-SEP-23. REMARK 100 THE DEPOSITION ID IS D_1300041401. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-FEB-22 REMARK 200 TEMPERATURE (KELVIN) : 298 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : DIAMOND REMARK 200 BEAMLINE : I03 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97626 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 16M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 24659 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.880 REMARK 200 RESOLUTION RANGE LOW (A) : 56.960 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 13.00 REMARK 200 R MERGE (I) : 0.16800 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.88 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.92 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 1.21300 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 41.98 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.12 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SM5-E1+30%GLY, VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 23.00500 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 56.96000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 27.90500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 56.96000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 23.00500 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 27.90500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 140 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 14710 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: 0.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A -22 REMARK 465 HIS A -21 REMARK 465 HIS A -20 REMARK 465 HIS A -19 REMARK 465 HIS A -18 REMARK 465 HIS A -17 REMARK 465 HIS A -16 REMARK 465 SER A -15 REMARK 465 SER A -14 REMARK 465 GLY A -13 REMARK 465 GLN A -2 REMARK 465 SER A -1 REMARK 465 MET A 0 REMARK 465 HIS A 75 REMARK 465 GLY A 262 REMARK 465 ALA A 263 REMARK 465 GLY A 264 REMARK 465 GLU A 265 REMARK 465 VAL A 266 REMARK 465 PRO A 362 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ARG A 360 NE - CZ - NH1 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 77 3.23 -65.67 REMARK 500 GLU A 87 -26.84 -146.43 REMARK 500 ALA A 88 -19.49 85.59 REMARK 500 VAL A 164 -74.69 -60.59 REMARK 500 ASP A 233 47.17 -145.23 REMARK 500 PRO A 243 -158.33 -5.92 REMARK 500 ASP A 251 76.07 60.01 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLY A 242 PRO A 243 -86.50 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 GLY A 242 -11.05 REMARK 500 REMARK 500 REMARK: NULL DBREF 8WJY A 75 362 UNP Q99640 PMYT1_HUMAN 75 362 SEQADV 8WJY MET A -22 UNP Q99640 INITIATING METHIONINE SEQADV 8WJY HIS A -21 UNP Q99640 EXPRESSION TAG SEQADV 8WJY HIS A -20 UNP Q99640 EXPRESSION TAG SEQADV 8WJY HIS A -19 UNP Q99640 EXPRESSION TAG SEQADV 8WJY HIS A -18 UNP Q99640 EXPRESSION TAG SEQADV 8WJY HIS A -17 UNP Q99640 EXPRESSION TAG SEQADV 8WJY HIS A -16 UNP Q99640 EXPRESSION TAG SEQADV 8WJY SER A -15 UNP Q99640 EXPRESSION TAG SEQADV 8WJY SER A -14 UNP Q99640 EXPRESSION TAG SEQADV 8WJY GLY A -13 UNP Q99640 EXPRESSION TAG SEQADV 8WJY VAL A -12 UNP Q99640 EXPRESSION TAG SEQADV 8WJY ASP A -11 UNP Q99640 EXPRESSION TAG SEQADV 8WJY LEU A -10 UNP Q99640 EXPRESSION TAG SEQADV 8WJY GLY A -9 UNP Q99640 EXPRESSION TAG SEQADV 8WJY THR A -8 UNP Q99640 EXPRESSION TAG SEQADV 8WJY GLU A -7 UNP Q99640 EXPRESSION TAG SEQADV 8WJY ASN A -6 UNP Q99640 EXPRESSION TAG SEQADV 8WJY LEU A -5 UNP Q99640 EXPRESSION TAG SEQADV 8WJY TYR A -4 UNP Q99640 EXPRESSION TAG SEQADV 8WJY PHE A -3 UNP Q99640 EXPRESSION TAG SEQADV 8WJY GLN A -2 UNP Q99640 EXPRESSION TAG SEQADV 8WJY SER A -1 UNP Q99640 EXPRESSION TAG SEQADV 8WJY MET A 0 UNP Q99640 EXPRESSION TAG SEQRES 1 A 311 MET HIS HIS HIS HIS HIS HIS SER SER GLY VAL ASP LEU SEQRES 2 A 311 GLY THR GLU ASN LEU TYR PHE GLN SER MET HIS GLN LEU SEQRES 3 A 311 GLN PRO ARG ARG VAL SER PHE ARG GLY GLU ALA SER GLU SEQRES 4 A 311 THR LEU GLN SER PRO GLY TYR ASP PRO SER ARG PRO GLU SEQRES 5 A 311 SER PHE PHE GLN GLN SER PHE GLN ARG LEU SER ARG LEU SEQRES 6 A 311 GLY HIS GLY SER TYR GLY GLU VAL PHE LYS VAL ARG SER SEQRES 7 A 311 LYS GLU ASP GLY ARG LEU TYR ALA VAL LYS ARG SER MET SEQRES 8 A 311 SER PRO PHE ARG GLY PRO LYS ASP ARG ALA ARG LYS LEU SEQRES 9 A 311 ALA GLU VAL GLY SER HIS GLU LYS VAL GLY GLN HIS PRO SEQRES 10 A 311 CYS CYS VAL ARG LEU GLU GLN ALA TRP GLU GLU GLY GLY SEQRES 11 A 311 ILE LEU TYR LEU GLN THR GLU LEU CYS GLY PRO SER LEU SEQRES 12 A 311 GLN GLN HIS CYS GLU ALA TRP GLY ALA SER LEU PRO GLU SEQRES 13 A 311 ALA GLN VAL TRP GLY TYR LEU ARG ASP THR LEU LEU ALA SEQRES 14 A 311 LEU ALA HIS LEU HIS SER GLN GLY LEU VAL HIS LEU ASP SEQRES 15 A 311 VAL LYS PRO ALA ASN ILE PHE LEU GLY PRO ARG GLY ARG SEQRES 16 A 311 CYS LYS LEU GLY ASP PHE GLY LEU LEU VAL GLU LEU GLY SEQRES 17 A 311 THR ALA GLY ALA GLY GLU VAL GLN GLU GLY ASP PRO ARG SEQRES 18 A 311 TYR MET ALA PRO GLU LEU LEU GLN GLY SER TYR GLY THR SEQRES 19 A 311 ALA ALA ASP VAL PHE SER LEU GLY LEU THR ILE LEU GLU SEQRES 20 A 311 VAL ALA CYS ASN MET GLU LEU PRO HIS GLY GLY GLU GLY SEQRES 21 A 311 TRP GLN GLN LEU ARG GLN GLY TYR LEU PRO PRO GLU PHE SEQRES 22 A 311 THR ALA GLY LEU SER SER GLU LEU ARG SER VAL LEU VAL SEQRES 23 A 311 MET MET LEU GLU PRO ASP PRO LYS LEU ARG ALA THR ALA SEQRES 24 A 311 GLU ALA LEU LEU ALA LEU PRO VAL LEU ARG GLN PRO HET W9X A 401 32 HET DMS A 402 4 HET GOL A 403 6 HETNAM W9X [6-AZANYL-5-(2,6-DIMETHYL-3-OXIDANYL-PHENYL)-2,3- HETNAM 2 W9X DIMETHYL-PYRROLO[2,3-B]PYRAZIN-7-YL]-(6,7-DIHYDRO- HETNAM 3 W9X 4~{H}-PYRAZOLO[1,5-A]PYRAZIN-5-YL)METHANONE HETNAM DMS DIMETHYL SULFOXIDE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 2 W9X C23 H25 N7 O2 FORMUL 3 DMS C2 H6 O S FORMUL 4 GOL C3 H8 O3 FORMUL 5 HOH *271(H2 O) HELIX 1 AA1 SER A 104 SER A 109 1 6 HELIX 2 AA2 GLY A 147 GLY A 165 1 19 HELIX 3 AA3 SER A 193 GLY A 202 1 10 HELIX 4 AA4 PRO A 206 GLN A 227 1 22 HELIX 5 AA5 LYS A 235 ALA A 237 5 3 HELIX 6 AA6 ASP A 251 LEU A 255 5 5 HELIX 7 AA7 ASP A 270 MET A 274 5 5 HELIX 8 AA8 ALA A 275 GLY A 281 5 7 HELIX 9 AA9 THR A 285 ASN A 302 1 18 HELIX 10 AB1 GLY A 308 LEU A 315 1 8 HELIX 11 AB2 PRO A 321 ALA A 326 1 6 HELIX 12 AB3 SER A 329 GLU A 341 1 13 HELIX 13 AB4 THR A 349 ALA A 355 1 7 HELIX 14 AB5 LEU A 356 ARG A 360 5 5 SHEET 1 AA1 6 ARG A 80 ARG A 81 0 SHEET 2 AA1 6 LEU A 173 GLU A 179 -1 O GLU A 178 N ARG A 80 SHEET 3 AA1 6 ILE A 182 GLU A 188 -1 O TYR A 184 N TRP A 177 SHEET 4 AA1 6 LEU A 135 SER A 141 -1 N ALA A 137 O THR A 187 SHEET 5 AA1 6 GLY A 122 SER A 129 -1 N GLU A 123 O ARG A 140 SHEET 6 AA1 6 PHE A 110 GLY A 119 -1 N LEU A 113 O LYS A 126 SHEET 1 AA2 2 LEU A 229 VAL A 230 0 SHEET 2 AA2 2 VAL A 256 GLU A 257 -1 O VAL A 256 N VAL A 230 SHEET 1 AA3 2 ILE A 239 LEU A 241 0 SHEET 2 AA3 2 CYS A 247 LEU A 249 -1 O LYS A 248 N PHE A 240 CRYST1 46.010 55.810 113.920 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.021734 0.000000 0.000000 0.00000 SCALE2 0.000000 0.017918 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008778 0.00000